- Home
- BVS vs BRSP Comparison
BVS vs BRSP Comparison
Compare BVS & BRSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BVS
- BRSP
- Stock Information
- Founded
- BVS 2011
- BRSP 2017
- Country
- BVS United States
- BRSP United States
- Employees
- BVS N/A
- BRSP N/A
- Industry
- BVS Biotechnology: Electromedical & Electrotherapeutic Apparatus
- BRSP Real Estate Investment Trusts
- Sector
- BVS Health Care
- BRSP Real Estate
- Exchange
- BVS Nasdaq
- BRSP Nasdaq
- Market Cap
- BVS 698.1M
- BRSP 730.1M
- IPO Year
- BVS 2021
- BRSP 2018
- Fundamental
- Price
- BVS $10.04
- BRSP $5.79
- Analyst Decision
- BVS Strong Buy
- BRSP Hold
- Analyst Count
- BVS 3
- BRSP 5
- Target Price
- BVS $15.00
- BRSP $7.06
- AVG Volume (30 Days)
- BVS 345.4K
- BRSP 631.6K
- Earning Date
- BVS 03-11-2025
- BRSP 02-19-2025
- Dividend Yield
- BVS N/A
- BRSP 11.05%
- EPS Growth
- BVS N/A
- BRSP N/A
- EPS
- BVS N/A
- BRSP N/A
- Revenue
- BVS $555,061,000.00
- BRSP $378,095,000.00
- Revenue This Year
- BVS $11.37
- BRSP N/A
- Revenue Next Year
- BVS $1.04
- BRSP N/A
- P/E Ratio
- BVS N/A
- BRSP N/A
- Revenue Growth
- BVS 10.40
- BRSP N/A
- 52 Week Low
- BVS $3.90
- BRSP $5.07
- 52 Week High
- BVS $14.38
- BRSP $7.71
- Technical
- Relative Strength Index (RSI)
- BVS 45.71
- BRSP 47.38
- Support Level
- BVS $8.77
- BRSP $5.40
- Resistance Level
- BVS $10.90
- BRSP $5.85
- Average True Range (ATR)
- BVS 0.50
- BRSP 0.14
- MACD
- BVS 0.03
- BRSP 0.01
- Stochastic Oscillator
- BVS 57.99
- BRSP 66.10
About BVS Bioventus Inc.
Bioventus Inc is a medical technology company. The company is engaged in developing and commercializing clinically differentiated treatments that engage and enhance the body's natural healing process. It offers a diverse portfolio of products to serve physicians spanning the orthopedic continuum, including sports medicine, total joint reconstruction, hand and upper extremities, foot and ankle, podiatric surgery, trauma, spine and neurosurgery. Its portfolio of products is grouped into three verticals based on clinical use: Pain Treatments, Surgical Solutions, and Restorative Therapies. Geographical presence is in the United States which derives key revenue, and International markets.
About BRSP BrightSpire Capital Inc.
BrightSpire Capital Inc is an internally-managed commercial real estate credit REIT focused on originating, acquiring, financing and managing a diversified portfolio of commercial real estate debt and net lease real estate investments predominantly in the United States. CRE debt investments consist of first mortgage loans with the objective of generating consistent risk-adjusted returns. The operating segments of the company are Senior and Mezzanine Loans and Preferred Equity, Net Leased and Other Real Estate, Corporate and Other. Geographically, the company generates revenue from the United States.